1. A group of normal and congenitally goitrous Merino sheep were investigated to identify the metabolic defect present in the abnormal animals. 2. Protein-bound iodine concentrations of serum from goitrous animals (average 5 7,ug./100ml.) were higher than normal (average 4 2,ug./100ml.; P 0.001), but the hormonal iodine measured as butanol-extractable 131I was low in the serum of goitrous (average 40-3% of protein-bound 131I) compared with that of normal (84-2%; P 0.02) sheep. The non-hormonal iodine of the serum of goitrous sheep appeared to include iodotyrosines and iodinated protein. 3. Starch-gel-electrophoretic separations of sera from normal and goitrous sheep after 131I injection (100-500,uc) showed no qualitative differences in the radioactivity of protein components. No significant differences in thyroxine-binding in vitro by serum proteins of normal and goitrous sheep were observed. 4. The clearance rates of 131I-labelled iodotyrosines (t* 1.2-2.9hr.) and iodothyronines (t* 33.5-47.4hr.) were similar in normal and goitrous sheep. 5. The concentration of circulating thyroid-stimulating hormone was significantly higher (P < 0*01 in three sheep, P < 0 05 in one sheep) in goitrous sheep. 6. The congenital goitre appears to be due to compensatory hypertrophy of the gland resulting from an inability to synthesize an adequate supply of thyroid hormone.
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The appearance of increasing numbers of South Australian Merino sheep born with enlarged thyroid glands prompted an investigation into the nature of this disorder. Preliminary genetic investigation indicated a congenital defect, unrelated to any environmental or dietary factor (G. Mayo, personal communication) . Most lambs having enlarged thyroid glands at birth died within a few weeks, but others survived to maturity with an increasingly large goitre.
Defects in the biosynthesis of thyroid hormones in man resulting in goitre have been described and fall into several distinct categories. The first identified was a defect in the ability of the thyroid to convert accumulated inorganic iodide into organically bound iodine (Stanbury & Hedge, 1950) , leading to a deficiency of thyroid hormone. This was expected to have caused an increased secretion of thyroid-stimulating hormone and to result in the large goitres present in recorded cases (Parker & Beierwaltes, 1961) .
Another thyroid defect of congenital origin was an inability to deiodinate free iodotyrosines, either in the gland itself or in peripheral tissues  Choufoer, Kassenaar & Querido, 1960) . This led to an accumulation of iodotyrosines in the thyroid and release into the blood. Most of intravenously administered doses of iodotyrosine was recovered in the urine, which demonstrated the lack of deiodination in the body as a whole. Goitre in these cases was assumed to be due to iodide deficiency, caused by the loss of iodotyrosines in the urine.
Defects in the biosynthesis of iodothyronines from iodotyrosines have also been implicated as causes of congenital goitre (Werner, Block, Mandl & Kassenaar, 1957) but the actual nature of these defects is as yet undecided. The presence ofabnormal iodinated proteins, which may arise from the thyroid gland, has been described in the blood of some congenitally goitrous patients (Dowling, Ingbar & Freinkel, 1961 iodotyrosines were prepared by the method of Lemmon, Tarpey & Scott (1950) .
Methods. The analyses of protein-bound iodine were carried out by the method of Acland (1957) . Butan-l-olextractable 131I was estimated by the method of Man, Kydd & Peters (1951) , the procedure being terminated after evaporation of the alkali-washed butan-l-ol extracts to 0-5 ml. Protein-bound 131I was determined as described by Falconer (1963) .
Starch-gel electrophoresis of serum was carried out in a vertical apparatus (Graham, 1963) with a discontinuous buffer system [gel buffer: 9vol. of 3mm-citric acid-0-16x-tris (Sigma Chemical Co.) plus lvol. of 20mw-LiOH76mm-boric acid, final pH9-4; electrolyte buffer: 0-1N-LiOH-0-38X-boric acid, final pH8-5].
Assay ofthyroxine-binding proteins was done as described by Good, Potter & Hetzel (1965) di-iodotyrosine, 2-8% free iodide) containing 0-57,uc/4g., a dose of 56,ug. in 1 ml. of 0-9% NaCl being injected intravenously into each animal. A mixture of iodotyrosines was used, since both occur in thyroid tissue. Blood samples were taken up to 3hr. after injection. One sample of each serum obtained was used for the determination of butan-I-ol-extractable 131I and was measured for L31I in a well scintillation counter as whole serum, as acid-butan-l-ol extract and as alkali-washed butan-l-ol extract. The alkaline washing of the butan-l-ol extract removes iodotyrosines and any inorganic iodide (Man et al. 1951) . A further sample was measured for protein-bound lsI content and the remainder acidified with 1 ml. of N-HCl to 3ml. of serum, 20,ug. of L-monoiodotyrosine, 20kg. of L-di-iodotyrosine and 50,ug. of KI were added and the whole was extracted with three equal volumes of 0-1 N-HCIsaturated butan-l-ol. The butan-l-ol extract was evaporated to dryness and the residue taken up in 0-2ml. of butan-l-ol. Portions of this were spotted on Whatman no. 1 chromatography paper and one-dimensional separation (descending) was carried out with butan-l-ol-acetic acidwater (74:19:51, by vol). After separation the chromatography paper was cut into 1 cm. strips for well scintillation counting of 131I.
For measurement of thyroid-stimulating hormone, blood was obtained by jugular puncture, allowed to clot for 1-2hr. and The concentrations of hormone 131I in the sera Vol. 100 Table 1 . lodinated components of serum in normal and goitrous sheep Analyses for protein-bound iodine and protein-bound 131I of the serum were carried out as described in the text. Measurements of the radioactivity of the acid-butan-l-ol-extractable 1311 were done before and after alkaline washing of the butan-l-ol extract. The results were corrected for radioactive decay to the time of blood sampling. In this and subsequent Tables the numbers of normal of normal sheep (Table 1) show that almost all the protein-bound 131I is hormone; however, the sera of goitrous sheep show a much lower proportion (29-53%) of hormone in the protein-bound 131I, as measured by the results for the butan-l-olextractable 131I (Man et al. 1951 ). The low concentrations of hormone iodine, calculated from these results (1-5-3-0,ug./100ml.), in the sera of goitrous sheep demonstrates the cause of decreased viability at birth and in some cases the poor growth of the few surviving animals.
The total amount of iodinated material bound to serum proteins in the goitrous sheep is 1-3-1-4 times the normal. In a group of congenitally goitrous cattle the protein-bound iodine concentrations were shown to be approx. 10 times the normal (Van Zyl, Schulz, Wilson & Pansegrouw, 1965) . The radioactivity of acid-butanol-precipitated proteins ( Several studies of congenital goitre in man (Wiener & Lindeboom, 1963; Fraser, 1964) In confirmation of this, iodotyrosines were observed after chromatographic separation of extracts of serum from goitrous sheep. Iodotyrosines have also been demonstrated in the serum of patients with congenitally defective mechanisms for deiodinating these compounds, which resulted in goitre (Stanbury, Kassenaar, Meijer & Terpstra, 1955) .
Results obtained for the sheep given 1mg. of L-thyroxine/day show a markedly low level of endogenous thyroid-hormone production as measured by butan-l-ol-extractable 131J, with a very high concentration of circulating thyroid hormone. This indicates the normal suppression of thyroid activity by high concentrations of exogenous hormone, which is in agreement with the elevated free [131I]iodide concentration of the serum.
To identify the serum proteins transporting the iodinated compounds in the blood of normal and of goitrous sheep, a series of starch-gel-electrophoretic separations were carried out on sera from sheep injected with 100 ,uc (normal) or 500/,c (goitrous sheep) of [1311]iodide 96hr. previously. The serum proteins were separated in a discontinuous buffer system, described above, at 5v/cm. for 18hr. The gel after separation was sliced into two layers, the upper being stained for protein (Graham, 1963) and the lower cut up into lcm. strips for radioactivity measurement on a well scintillation counter. The results of a representative separation are presented in Fig. 1 . No qualitative differences were observed between serum-protein radioactivities of normal and goitrous sheep. This indicates that no unique iodoprotein occurred in the serum of goitrous animals, unless it was similar in electrophoretic mobility to a-globulin or albumin, in which case it would not be observed. In both groups of animals clear peaks of 131I radioactivity occurred close to the transferrins (ac-globulins) and superimposed on the front edge of albumin. This distribution of radioactivity is similar to that described by Dowling et at. (1961) in goitrous human adults.
To measure quantitatively any differences in thyroxine-binding between the serum proteins of normal and goitrous sheep, fresh serum samples were incubated for 3hr. at 370 with L-[131I]thyroxine (IO,ug . of thyroxine/lOOml. of serum) and the serum proteins separated by reverse-flow paper electrophoresis (Elzinga, Carr & Beierwaltes, 1961) . This quantity of exogenous thyroxine more than doubled the normal concentration of thyroxine in sheep serum, and therefore differences in the amount of L-[131I]thyroxine bound to serum proteins would indicate differences in affinity of binding. Duplicate electrophoretic separations were carried out on each serum sample, one paper strip being cut into 0-5cm. sections for radioactivity measurement and the other used to prepare a radioautograph. The second strip was finally stained for protein with bromophenol blue (Durrum, 1950) . Radioactivity was present only in two protein bands, corresponding to albumin and the a-globulin region. The proportions of labelled thyroxine in each zone are shown in Table 2 . These results indicate a close similarity in the proportion of thyroxine bound by albumin and ac-globulin in sera from normal and goitrous sheep. No other zones of radioactivity were observed. It is therefore apparent that no major defect in thyroxinebinding by serum proteins exists in the goitrous sheep.
Metaboli8m of thyroxine and iodotyro8ine8.
L-[1311]Thyroxine (25,uc/1-6,g.) in 0-9% sodium chloride solution was injected intravenously into normal and goitrous sheep. At intervals up to 75hr. after injection blood samples were withdrawn and the sera measured for total radioactivity, protein-bound 131I and butan-1 -ol-extractable 131I. The results of the analyses for protein-bound 131I are given in Fig. 2 . Calculations of the half-life of L-[131I]thyroxine in normal and goitrous sheep are given in Table 3 . Annison & Lewis (1959) used this technique on normal non-pregnant sheep, and showed an average half-life for circulating thyroxine of 37-lhr. (range 33-44hr.) . This is in close agreement with the results given in Table 3 , indicating that no extra thyroidal defect in thyroxine metabolism occurs in the goitrous sheep. The clearance of iodotyrosines from the blood was measured after the intravenous injection of L-[131I]iodotyrosines (32,uc/56,ug. in lml. of 0-9% sodium chloride solution) into normal and goitrous sheep. Blood samples were withdrawn at intervals up to 3hr. after injection. Serum from these Bioch. 1966, 100 Table 3 . In cases of human congenital goitre in which iodotyrosine deiodinase is lacking, marked increases in the measured half-life of iodotyrosine in the serum are observed (Stanbury, Kassenaar, Meijer & Terpstra, 1955 . It is clear from Table 3 that there are no major differences in the halflife of L- [1311] iodotyrosines between normal and goitrous sheep. As the observed half-life is short, the presence of iodotyrosines in the blood of these goitrous animals indicates a substantial continuous release of iodotyrosines from the thyroid.
Thyroid-atimulattng hormone. In animals or patients having large goitres and a low concentration of circulating thyroid hormone it is likely that the output of thyroid-stimulating hormone from the pituitary will be much higher than normal. It was therefore decided to estimate the concentration of thyroid-stimulating hormone in the blood of normal and goitrous sheep. Samples of blood were withdrawn from normal and goitrous sheep, and the sera separated. Estimation of the content of thyroid-stimulating hormone was carried out by the method of McKenzie (1958b), as described above. The results are expressed as percentage increase in 131I concentration in the blood of mice receiving injections of the sample serum. Each serum was administered to five mice, and five other mice received 0O2milliunit of thyroid-stimulating hormone for comparative purposes. The results are presented in Table 4 , which shows that 3hr. after the injection of 0*5ml. of goitrous-sheep serum into mice the increase in mouse-blood radioactivity is significantly greater (P < 0.01) than after the injection of normal sheep serum. The increase in blood radioactivity after 0O2 milliunit of thyroidstimulating hormone is lower than the average for the goitrous serum, indicating that the goitrous serum contains about 0.4milliunit/ml. The decreased blood radioactivity after 8hr. shown in Table 4 is an effective demonstration that the stimulating hormone in the goitrous-sheep serum does not have long-acting thyroid-stimulator activity (Adams, 1958; McKenzie, 1958a,b) .
It is therefore concluded that, although the iodinated compounds of the serum are abnormal, no defect in the transport or peripheral metabolism of thyroxine or iodotyrosines exists in these goitrous sheep. The low concentration of circulating thyroid hormones, and elevated concentration of thyroid-stimulating hormone, indicate that the goitre is a result of compensatory enlargement of the gland. The congenital defect may therefore be expected to be in the biosynthesis of hormone in the goitrous gland, and the abnormal consequences described in this paper arise from that defect.
